» Articles » PMID: 9153155

The Neuropsychiatric Inventory: Assessing Psychopathology in Dementia Patients

Overview
Journal Neurology
Specialty Neurology
Date 1997 May 1
PMID 9153155
Citations 735
Authors
Affiliations
Soon will be listed here.
Abstract

The Neuropsychiatric Inventory (NPI) was developed to assess psychopathology in dementia patients. It evaluates 12 neuropsychiatric disturbances common in dementia: delusions, hallucinations, agitation, dysphoria, anxiety, apathy, irritability, euphoria, disinhibition, aberrant motor behavior, night-time behavior disturbances, and appetite and eating abnormalities. The severity and frequency of each neuropsychiatric symptom are rated on the basis of scripted questions administered to the patient's caregiver. The NPI also assesses the amount of caregiver distress engendered by each of the neuropsychiatric disorders. A total NPI score and a total caregiver distress score are calculated, in addition to the scores for the individual symptom domains. Content validity, concurrent validity, inter-rater reliability, and test-retest reliability of the NPI are established. Different neurologic disorders have characteristic neuropsychiatric manifestations and distinctive NPI profiles. The NPI is sensitive to treatment effects and has demonstrated the amelioration of behavioral symptoms in Alzheimer's disease by cholinergic agents. The NPI is a useful instrument for characterizing the psychopathology of dementia syndromes, investigating the neurobiology of brain disorders with neuropsychiatric manifestations, distinguishing among different dementia syndromes, and assessing the efficacy of treatment.

Citing Articles

Phase 2 study of palmitoylethanolamide combined with luteoline in frontotemporal dementia patients.

Assogna M, Di Lorenzo F, Bonni S, Borghi I, Cerulli Irelli E, Mencarelli L Brain Commun. 2025; 7(2):fcaf080.

PMID: 40046339 PMC: 11881584. DOI: 10.1093/braincomms/fcaf080.


A progranulin gene deletion in frontotemporal lobar degeneration with corticobasal syndrome in a TREDEM case report.

Gallucci M, Da Ronch C, Bendini M, Fiore V, Turolla L, Ferrarini M J Alzheimers Dis Rep. 2025; 8(1):1649-1660.

PMID: 40034355 PMC: 11863730. DOI: 10.1177/25424823241302743.


Anticholinergic burden and behavioral and psychological symptoms in older patients with cognitive impairment.

Pistorio S, Scotto di Tella G, Canzanella V, Merenda R, Cuomo G, Iacotucci P Front Med (Lausanne). 2025; 12:1505007.

PMID: 40012975 PMC: 11861190. DOI: 10.3389/fmed.2025.1505007.


The Implementation of Infant Anoesis and Adult Autonoesis in the Retrogenesis and Staging System of the Neurocognitive Disorders: A Proposal for a Multidimensional Person-Centered Model.

Pirani A Geriatrics (Basel). 2025; 10(1).

PMID: 39997519 PMC: 11854936. DOI: 10.3390/geriatrics10010020.


Prediction of cognitive conversion within the Alzheimer's disease continuum using deep learning.

Yang S, Zhang X, Du X, Yan P, Zhang J, Wang W Alzheimers Res Ther. 2025; 17(1):41.

PMID: 39948600 PMC: 11823042. DOI: 10.1186/s13195-025-01686-x.